NASDAQ:GILD
$80.00
(
1.57%
)
Friday, 24th Mar 2023
Gilead Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $76.53 | $84.75 | Friday, 24th Mar 2023 GILD stock ended at $80.00. This is 1.57% more than the trading day before Thursday, 23rd Mar 2023. During the day the stock fluctuated 2.64% from a day low at $78.33 to a day high of $80.40. |
| 90 days | $76.53 | $88.29 | |
| 52 weeks | $57.17 | $89.74 |
Historical Gilead Sciences prices
| Date | Open | High | Low | Close | Volume |
| 2016-06-23 | $83.29 | $83.58 | $82.54 | $82.87 | 5 844 000 |
| 2016-06-22 | $81.56 | $83.79 | $81.56 | $81.95 | 10 069 600 |
| 2016-06-21 | $83.35 | $83.44 | $81.43 | $81.30 | 8 412 000 |
| 2016-06-20 | $83.26 | $84.12 | $82.90 | $82.49 | 6 951 800 |
| 2016-06-17 | $83.68 | $84.17 | $82.53 | $82.15 | 15 951 300 |
| 2016-06-16 | $82.78 | $83.70 | $82.23 | $83.51 | 6 165 271 |
| 2016-06-15 | $83.04 | $84.44 | $82.97 | $83.04 | 7 366 387 |
| 2016-06-14 | $83.50 | $84.56 | $82.77 | $83.57 | 7 481 990 |
| 2016-06-13 | $84.00 | $84.81 | $83.90 | $83.98 | 8 180 270 |
| 2016-06-10 | $84.98 | $85.17 | $84.08 | $84.45 | 8 029 233 |
| 2016-06-09 | $86.92 | $87.25 | $85.65 | $85.77 | 8 049 889 |
| 2016-06-08 | $87.52 | $88.09 | $86.82 | $87.42 | 7 271 410 |
| 2016-06-07 | $87.54 | $88.24 | $86.90 | $87.50 | 7 917 560 |
| 2016-06-06 | $86.17 | $87.87 | $86.10 | $87.60 | 8 581 820 |
| 2016-06-03 | $86.85 | $86.98 | $85.55 | $86.15 | 7 438 574 |
| 2016-06-02 | $86.69 | $87.07 | $85.86 | $86.72 | 7 273 191 |
| 2016-06-01 | $87.23 | $87.30 | $86.31 | $86.58 | 7 441 424 |
| 2016-05-31 | $86.35 | $87.23 | $86.05 | $87.06 | 12 298 054 |
| 2016-05-27 | $85.82 | $86.02 | $85.20 | $85.82 | 6 122 890 |
| 2016-05-26 | $86.44 | $86.50 | $85.05 | $85.29 | 7 988 538 |
| 2016-05-25 | $86.80 | $87.00 | $85.70 | $86.51 | 11 621 385 |
| 2016-05-24 | $83.78 | $86.44 | $83.71 | $86.22 | 13 139 610 |
| 2016-05-23 | $82.53 | $84.03 | $82.25 | $83.33 | 7 773 171 |
| 2016-05-20 | $82.17 | $83.08 | $82.07 | $82.64 | 7 927 616 |
| 2016-05-19 | $82.31 | $82.59 | $81.28 | $82.14 | 9 243 876 |
| 2016-05-18 | $82.54 | $83.44 | $82.33 | $82.88 | 7 475 103 |
| 2016-05-17 | $83.57 | $83.74 | $82.45 | $82.76 | 8 364 488 |
| 2016-05-16 | $82.70 | $83.83 | $82.50 | $83.61 | 6 490 416 |
| 2016-05-13 | $82.45 | $83.87 | $82.41 | $82.70 | 8 303 061 |
| 2016-05-12 | $84.10 | $84.30 | $81.70 | $82.76 | 12 075 714 |
| 2016-05-11 | $86.30 | $86.40 | $83.81 | $83.90 | 8 433 566 |
| 2016-05-10 | $86.41 | $86.48 | $84.89 | $86.18 | 6 824 648 |
| 2016-05-09 | $84.99 | $86.46 | $84.70 | $85.67 | 8 451 565 |
| 2016-05-06 | $85.67 | $85.84 | $84.04 | $84.68 | 9 249 866 |
| 2016-05-05 | $86.35 | $86.40 | $85.20 | $85.86 | 8 018 785 |
| 2016-05-04 | $86.66 | $86.99 | $85.41 | $85.60 | 12 058 238 |
| 2016-05-03 | $88.50 | $89.12 | $87.00 | $87.17 | 9 751 960 |
| 2016-05-02 | $88.70 | $89.45 | $86.75 | $89.00 | 13 472 146 |
| 2016-04-29 | $91.19 | $92.53 | $87.80 | $88.21 | 33 471 416 |
| 2016-04-28 | $100.41 | $100.75 | $96.80 | $97.00 | 15 051 991 |
| 2016-04-27 | $101.30 | $101.78 | $100.15 | $100.72 | 8 560 962 |
| 2016-04-26 | $102.02 | $103.10 | $101.01 | $101.33 | 9 299 042 |
| 2016-04-25 | $101.84 | $102.38 | $101.50 | $102.29 | 8 278 253 |
| 2016-04-22 | $101.56 | $102.45 | $100.50 | $101.93 | 10 227 016 |
| 2016-04-21 | $99.91 | $101.84 | $99.90 | $101.74 | 8 981 491 |
| 2016-04-20 | $99.50 | $100.96 | $99.35 | $100.11 | 8 856 576 |
| 2016-04-19 | $99.68 | $100.73 | $99.24 | $99.44 | 9 780 079 |
| 2016-04-18 | $98.22 | $99.73 | $98.11 | $99.20 | 8 059 688 |
| 2016-04-15 | $98.53 | $98.98 | $97.62 | $98.29 | 8 907 746 |
| 2016-04-14 | $97.01 | $98.77 | $96.90 | $98.19 | 8 737 235 |
About Gilead Sciences
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, V... GILD Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
